Carlos Rojas-Roque

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Venues

PharmacoEconomics - open

PloS one

International journal for equity in health

Applied health economics and health policy

Instituto de Efectividad Clínica y Sanitaria

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto de Efectividad Clínica y Sanitaria Apr 01 2019 - Dec 31 2019

Argentina

Becario de Investigación :: Departamento de Evaluación de Tecnología Sanitaria y Economía de la Salud

Universidad Autónoma de Chianandega

Nicaragua

Profesor Principal :: Facultad de Ciencias Económicas

Centro de Investigación en Demografía y Salud, CIDS UNAN León

Nicaragua

Asistente de Investigación :: Economía y Salud

Publications

Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open 8 (4) (2024)
Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open 8 (4) (2024)
Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open 8 (5) (2024)
Natalia Espinola, Federico Rodriguez Cairoli, Carlos Rojas-Roque, Paula Carolina Luna, Diego Kanevsky, Valeria Migliazza, Andrés Pichon-Riviere
Budget impact and cost per responder analysis of upadacitinib for the treatment of moderate to severe atopic dermatitis from the perspective of the social security and the private sector in Argentina. Expert review of pharmacoeconomics & outcomes research (2024)
Renato Díaz Ruiz, Rodrigo Vargas-Fernández, Carlos Rojas-Roque, Akram Hernández-Vásquez
Socioeconomic inequalities in the use of medical consultation services in Peru, 2019. International journal for equity in health 23 (1) (2024)
Alfredo Palacios, Natalia Espinola, Juan Martin Gonzalez, Carlos Rojas-Roque, Maria Marta Rivas, Diego Kanevski, Pierre Morisset, Federico Augustovski, Andres Pichon-Riviere, Ariel Bardach
Budget impact analysis of venetoclax for the management of acute myeloid leukemia from the perspective of the social security and the private sector in Argentina. PloS one 19 (1) (2024)
Alfredo Palacios, Natalia Espinola, Juan Martin Gonzalez, Carlos Rojas-Roque, Maria Marta Rivas, Diego Kanevski, Pierre Morisset, Federico Augustovski, Andres Pichon-Riviere, Ariel Bardach
Budget impact analysis of venetoclax for the management of acute myeloid leukemia from the perspective of the social security and the private sector in Argentina. PloS one 19 (1) (2024)
Natalia Espinola, Federico Rodriguez Cairoli, Carlos Rojas-Roque, Paula Carolina Luna, Diego Kanevsky, Valeria Migliazza, Andrés Pichon-Riviere
Budget impact and cost per responder analysis of upadacitinib for the treatment of moderate to severe atopic dermatitis from the perspective of the social security and the private sector in Argentina. Expert review of pharmacoeconomics & outcomes research (2024)
Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open 8 (5) (2024)
Alfredo Palacios, Natalia Espinola, Juan Martin Gonzalez, Carlos Rojas-Roque, Maria Marta Rivas, Diego Kanevski, Pierre Morisset, Federico Augustovski, Andres Pichon-Riviere, Ariel Bardach
Budget impact analysis of venetoclax for the management of acute myeloid leukemia from the perspective of the social security and the private sector in Argentina. PloS one 19 (1) (2024)
Alfredo Palacios, Natalia Espinola, Juan Martin Gonzalez, Carlos Rojas-Roque, Maria Marta Rivas, Diego Kanevski, Pierre Morisset, Federico Augustovski, Andres Pichon-Riviere, Ariel Bardach
Budget impact analysis of venetoclax for the management of acute myeloid leukemia from the perspective of the social security and the private sector in Argentina. PloS one 19 (1) (2024)
Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open 8 (5) (2024)
Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open (2024)
Renato Díaz Ruiz, Rodrigo Vargas-Fernández, Carlos Rojas-Roque, Akram Hernández-Vásquez
Socioeconomic inequalities in the use of medical consultation services in Peru, 2019. International journal for equity in health 23 (1) (2024)
Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open (2024)
Renato Díaz Ruiz, Rodrigo Vargas-Fernández, Carlos Rojas-Roque, Akram Hernández-Vásquez
Socioeconomic inequalities in the use of medical consultation services in Peru, 2019. International journal for equity in health 23 (1) (2024)
Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open 8 (4) (2024)
Alfredo Palacios, Federico Rodriguez Cairoli, Dario Balan, Carlos Rojas-Roque, Carolina Moreno-López, Barbara Braun, Federico Augustovski, Andrés Pichon-Riviere, Ariel Esteban Bardach
Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System ® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections in Argentina. Applied health economics and health policy (2023)
Carlos Rojas-Roque, Alfredo Palacios
A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America. Applied health economics and health policy (2023)
Alfredo Palacios, Carlos Rojas-Roque, Dario Balan, Isabela Sosa Estani, José M Belizán, Gabriela Cormick, Federico Augustovski
Fortification of staple foods with calcium: a novel costing tool to inform decision making. Annals of the New York Academy of Sciences 1513 (1) (2022)
Agustín Ciapponi, Federico Rodriguez Cairoli, Germán Solioz, Carlos Rojas-Roque, Akram Hernández-Vásquez, Alfredo Palacios, Ariel Esteban Bardach
Switching from cigarettes to electronic nicotine delivery system: rapid systematic review and meta-analysis and economic aspects. Revista peruana de medicina experimental y salud publica 38 (4) (2022)
Carlos Rojas-Roque, Akram Hernández-Vásquez, Diego Azañedo, Guido Bendezú-Quispe
Socioeconomic Inequalities in the Prevalence of Diabetes in Argentina: A Repeated Cross-Sectional Study in Urban Women and Men. International journal of environmental research and public health 19 (15) (2022)
Andrea Alcaraz, Andres Pichon-Riviere, Carlos Rojas-Roque, Juan Martín González, Daniela Prina, Germán Solioz, Federico Augustovski, Alfredo Palacios
Cost-effectiveness of a centrifugal-flow pump for patients with advanced heart failure in Argentina. PloS one 17 (8) (2022)
Akram Hernández-Vásquez, Carlos Rojas-Roque, Antonio Barrenechea-Pulache, Guido Bendezú-Quispe
Measuring the Protective Effect of Health Insurance Coverage on Out-of-Pocket Expenditures During the COVID-19 Pandemic in the Peruvian Population. International journal of health policy and management (2021)
Alfredo Palacios, Carlos Rojas-Roque, Lucas González, Ariel Bardach, Agustín Ciapponi, Claudia Peckaitis, Andres Pichon-Riviere, Federico Augustovski
Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review. PharmacoEconomics 39 (5) (2021)
Christian E Toval-Ruíz, Carlos Rojas-Roque, Akram Hernández-Vásquez
Predictors and geographic analysis of road traffic accidents in Leon, Nicaragua. Revista brasileira de epidemiologia = Brazilian journal of epidemiology 24 (2020)
Rodrigo Vargas-Fernández, Carlos Rojas-Roque, Marilina Santero, Fernando M Runzer-Colmenares, Wilma Figueroa
Substance abuse in adolescents before admission to Peruvian juvenile detention centers: results from a national census in Peru, 2016. International journal of adolescent medicine and health (2019)

Carlos Rojas-Roque.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Carlos Rojas-Roque